| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2010 | US20100004275 Agent for suppressing development of tolerance to narcotic analgesics |
| 01/07/2010 | US20100004274 Stable pharmaceutical compositions comprising a pyrimidine-sulfamide |
| 01/07/2010 | US20100004273 Compounds And Methods For Treating Disorders Related To Glucose Metabolism |
| 01/07/2010 | US20100004272 Modulators of metabolism and the treatment of disorders related thereto |
| 01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
| 01/07/2010 | US20100004270 Inhibitors of bruton's tyrosine kinase |
| 01/07/2010 | US20100004269 5-anilinoimidazopyridines and methods of use |
| 01/07/2010 | US20100004268 Optically Pure Dihydropyrimidine Compounds and Their Uses for the Preparation of a Medicament for Treatment and Prevention of Viral Diseases |
| 01/07/2010 | US20100004267 Liquid preparation |
| 01/07/2010 | US20100004266 Salt or Solvate of 5-Methyl-2(Piperazin-1-Yl)Benzenesulfonic Acid |
| 01/07/2010 | US20100004265 1,2,3-triazole derivatives as sigma receptor inhibitors |
| 01/07/2010 | US20100004264 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/07/2010 | US20100004263 Mtp inhibiting aryl piperidines or peperazines substituted with5-membered heterocycles |
| 01/07/2010 | US20100004262 Pharmaceutical compositions of aripiprazole |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004260 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 01/07/2010 | US20100004259 Tartrate Salt of (7S)-7-[(5-Fluoro-2-Methyl-Benzyl)oxy]-2-[(2R)-2-Methylpiperazin-1-YL]-6,7-Dihydro-5H-Cyclopenta[B]Pyridine |
| 01/07/2010 | US20100004258 Novel Heterocyclic NF-kB Inhibitors |
| 01/07/2010 | US20100004257 Identification of Biomarkers Predictive of Dasatinib Effects in Cancer Cells |
| 01/07/2010 | US20100004256 Heteroaryl-fused macrocyclic pyrimidine derivatives |
| 01/07/2010 | US20100004255 Method of treating arrhythmias |
| 01/07/2010 | US20100004254 Therapeutic agents useful for treating pain |
| 01/07/2010 | US20100004253 Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors |
| 01/07/2010 | US20100004252 Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain |
| 01/07/2010 | US20100004251 Dopamine-Agonist Combination Therapy For Improving Sleep Quality |
| 01/07/2010 | US20100004250 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 01/07/2010 | US20100004249 Bicyclic heterocyclic compound and use thereof |
| 01/07/2010 | US20100004248 Use of a Nitric Oxide Synthase Modulator for the Treatment of Cardiac Indications |
| 01/07/2010 | US20100004247 Combination comprising a mek inhibitor and an aurora kinase inhibitor 188 |
| 01/07/2010 | US20100004246 Novel triazinedione derivatives as gabab receptor modulators |
| 01/07/2010 | US20100004245 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/07/2010 | US20100004244 Use of cb2 receptor agonists for promoting neurogenesis |
| 01/07/2010 | US20100004243 Pharmaceutical compounds |
| 01/07/2010 | US20100004242 Process for the preparation of aprepitant |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004240 Indole Compounds |
| 01/07/2010 | US20100004239 Pyrrolo [3,2-C] Pyridine-4-One 2-Indolinone Protein Kinase Inhibitors |
| 01/07/2010 | US20100004238 Fused heterocyclic compound |
| 01/07/2010 | US20100004237 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases; heat-shock protein 90 (HSP90) inhibitor |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004235 Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses |
| 01/07/2010 | US20100004234 Specific kinase inhibitors |
| 01/07/2010 | US20100004233 Novel coumarin derivative having antitumor activity |
| 01/07/2010 | US20100004232 Pharmaceutical Compounds |
| 01/07/2010 | US20100004231 Inhibitors of burton's tyrosine kinase |
| 01/07/2010 | US20100004230 Azatricyclic compounds and their use |
| 01/07/2010 | US20100004229 Potassium Channel Inhibitors |
| 01/07/2010 | US20100004228 calcitonin gene related peptide antagonists such as [(3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-[4-[1-(3-ethoxy-3-oxopropyl)piperidin-4-yl]piperidin-1-yl]-1-oxopropan-2-yl]4-(3-oxo-5-phenyl-1H-1,2,4-triazol-2-yl)piperidine-1-carboxylate; headaches; diabetes; irritable bowel syndrome; hot flashes |
| 01/07/2010 | US20100004227 Compositions and methods relating to novel compounds and targets thereof |
| 01/07/2010 | US20100004226 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/07/2010 | US20100004225 Controlled release aural pressure modulator compositions and methods for the treatment of otic disorders |
| 01/07/2010 | US20100004224 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/07/2010 | US20100004223 Crystalline Forms Of (R)-8-Chloro-1-Methyl-2,3,4,5-Tetrahydro-1H-3-Benzazepine Hydrochloride |
| 01/07/2010 | US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| 01/07/2010 | US20100004221 Thiazepine derivative |
| 01/07/2010 | US20100004220 Indenoisoquinolinone Analogs and Methods of Use Thereof |
| 01/07/2010 | US20100004219 Modulators of glucocorticoid receptor, ap-1, and/or nf-kappabeta activity and use thereof |
| 01/07/2010 | US20100004218 Bridged polycyclic compound based compositions for renal therapy |
| 01/07/2010 | US20100004217 Topical steroidal formulations |
| 01/07/2010 | US20100004216 Medicinal lipolysis of accumulation of fat |
| 01/07/2010 | US20100004215 Compositions of phosphodiesterase type iv inhibitors |
| 01/07/2010 | US20100004214 Sequential sprm/ progestin treatment |
| 01/07/2010 | US20100004213 Gene expression markers for inflammatory bowel disease |
| 01/07/2010 | US20100004212 Dual protection of medicinal- pharmaceutical products and new techniques for their application |
| 01/07/2010 | US20100004211 7-N-Substituted Phenyl Tetracycline Compounds |
| 01/07/2010 | US20100004210 Method and substances for treating t-cell mediated autoimmune diseases |
| 01/07/2010 | US20100004209 [(4-Oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives |
| 01/07/2010 | US20100004208 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 01/07/2010 | US20100004207 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 01/07/2010 | US20100004206 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 01/07/2010 | US20100004205 Pharmaceutical compositions |
| 01/07/2010 | US20100004204 Ros-sensitive iron chelators and methods of using the same |
| 01/07/2010 | US20100004203 Medicament for preventive and/or therapeutic treatment of bowel disease |
| 01/07/2010 | US20100004201 Cosmetic |
| 01/07/2010 | US20100004200 Meloxicam and glucosamine formulation and uses thereof |
| 01/07/2010 | US20100004199 Glycine betaine and its use |
| 01/07/2010 | US20100004198 Polysaccharide gel formulation having increased longevity |
| 01/07/2010 | US20100004196 Heparan sulfate proteoglycan composition and use thereof |
| 01/07/2010 | US20100004195 Decoy Influenza Therapies |
| 01/07/2010 | US20100004194 Use of isomaltulose in food products having a regenerative effect |
| 01/07/2010 | US20100004193 Combination therapy |
| 01/07/2010 | US20100004192 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
| 01/07/2010 | US20100004191 Compositions of S-adenosyl-L-methionine. |
| 01/07/2010 | US20100004190 Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof |
| 01/07/2010 | US20100004189 Compositions and methods for treating cystic fibrosis |
| 01/07/2010 | US20100004188 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 01/07/2010 | US20100004187 Cobalt-amine based metal complex as an antibacterial compound |
| 01/07/2010 | US20100004186 Antithrombotic Dual Inhibitors Comprising A Biotin Residue |
| 01/07/2010 | US20100004185 Extracts derived from sugar cane and a process for their manufacture |
| 01/07/2010 | US20100004184 Anti-hypercholesterolemic compounds |
| 01/07/2010 | US20100004181 Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl) pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonate |
| 01/07/2010 | US20100004179 Targeting of ews-fli1 as anti-tumor therapy |
| 01/07/2010 | US20100004171 Therapeutic Methods for Neuropathic Pain |
| 01/07/2010 | US20100004168 Use of Crystallin For The Modulation of Angiogenesis |
| 01/07/2010 | US20100004161 Toll Like Receptor 4 Dysfunction and the Biological Applications Thereof |
| 01/07/2010 | US20100004160 Substituted fused heterocyclic c-glycosides |
| 01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
| 01/07/2010 | US20100004158 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 01/07/2010 | US20100003353 Control of Blood Vessel Physiology to Treat Skin Disorders |
| 01/07/2010 | US20100003351 Compositions comprising rhodiola rosea and methods of use thereof |